Evaxion AS (EVAX)
4.32
+0.14
(+3.35%)
USD |
NASDAQ |
Apr 28, 16:00
4.39
+0.07
(+1.62%)
After-Hours: 20:00
Evaxion Research and Development Expense (TTM) : 9.988M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Novo Nordisk A/S | 7.923B |
| Ascendis Pharma A/S | 332.30M |
| DBV Technologies SA | 107.07M |
| Cellectis SA | 75.00M |
| Akari Therapeutics Plc | 2.820M |